Orchid Pharma Limited

Orchid Pharma Limitedverified

ORCHPHARMA.NS

Price:

$787.05

Market Cap:

$39.92B

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company's multi-therapeutic presence in anti-infectives, anti-inflammatory, central nervous system, cardiovascular segment, nutraceuticals, and other oral and sterile products, as well as offers new drug discovery systems and pharmaceutical research and development services. It also exports its products to approximately 40 c...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2002-07-01

Stock Exchange

NSE

Ticker

ORCHPHARMA.NS

The PE Ratio as of December 2025 (TTM) for Orchid Pharma Limited (ORCHPHARMA.NS) is 76.41

According to Orchid Pharma Limited’s latest financial reports and current stock price. The company's current PE Ratio is 76.41. This represents a change of 408.22% compared to the average of 15.03 of the last 4 quarters.

Orchid Pharma Limited (ORCHPHARMA.NS) Historical PE Ratio (quarterly & annually)

How has ORCHPHARMA.NS PE Ratio performed in the past?

The mean historical PE Ratio of Orchid Pharma Limited over the last ten years is -54.95. The current 76.41 PE Ratio has changed -14005.21% with respect to the historical average. Over the past ten years (40 quarters), ORCHPHARMA.NS's PE Ratio was at its highest in in the December 2024 quarter at 110.19. The PE Ratio was at its lowest in in the September 2025 quarter at -155.31.

Quarterly (TTM)
Annual

Average

-54.95

Median

-0.39

Minimum

-596.60

Maximum

58.06

Orchid Pharma Limited (ORCHPHARMA.NS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Orchid Pharma Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 6.81%

Maximum Annual PE Ratio = 58.06

Minimum Annual Increase = -608.37%

Minimum Annual PE Ratio = -596.60

Quarterly (TTM)
Annual
YearPE RatioChange
202539.84-31.37%
202458.0671.90%
202333.77-105.66%
2022-596.60607.47%
2021-84.336.81%
2020-1.22-152.86%
20192.31-608.37%
2018-0.4540.44%
2017-0.32-42.41%
2016-0.56-47.48%

Orchid Pharma Limited (ORCHPHARMA.NS) Average PE Ratio

How has ORCHPHARMA.NS PE Ratio performed in the past?

The current PE Ratio of Orchid Pharma Limited (ORCHPHARMA.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

43.89

5-year avg

-109.85

10-year avg

-54.95

Orchid Pharma Limited (ORCHPHARMA.NS) PE Ratio vs. Peers

How is ORCHPHARMA.NS’s PE Ratio compared to its peers?

Orchid Pharma Limited’s PE Ratio is greater than RPG Life Sciences Limited (17.99), greater than RPG Life Sciences Limited (17.99), greater than Shilpa Medicare Limited (57.21), greater than Gufic Biosciences Limited (61.40), greater than Gufic Biosciences Limited (61.40), greater than Unichem Laboratories Limited (24.16), greater than Unichem Laboratories Limited (24.16), less than Hikal Limited (289.51), greater than Innova Captab Limited (31.69), less than Hikal Limited (289.51),

Build a custom stock screener for Orchid Pharma Limited (ORCHPHARMA.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orchid Pharma Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Orchid Pharma Limited (ORCHPHARMA.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Orchid Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Orchid Pharma Limited's PE Ratio?

How is the PE Ratio calculated for Orchid Pharma Limited (ORCHPHARMA.NS)?

What is the highest PE Ratio for Orchid Pharma Limited (ORCHPHARMA.NS)?

What is the 3-year average PE Ratio for Orchid Pharma Limited (ORCHPHARMA.NS)?

What is the 5-year average PE Ratio for Orchid Pharma Limited (ORCHPHARMA.NS)?

How does the current PE Ratio for Orchid Pharma Limited (ORCHPHARMA.NS) compare to its historical average?